{
    "organizations": [],
    "uuid": "8bcf9b7c9a22595c5896f778617aa95078803d2c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-pacira-pharmaceuticals-says-fda-ad/brief-pacira-pharmaceuticals-says-fda-advisory-committee-to-review-snda-for-exparel-idUSFWN1Q41DW",
    "ord_in_thread": 0,
    "title": "BRIEF-Pacira Pharmaceuticals Says FDA Advisory Committee To Review SNDA For Exparel",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Pacira Pharmaceuticals Inc:\n* PACIRA PHARMACEUTICALS STOCK TRADING HALTED; FDA ADVISORY COMMITTEE TO REVIEW SNDA FOR EXPARELÂ® AS A NERVE BLOCK FOR REGIONAL ANALGESIA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-15T03:52:00.000+02:00",
    "crawled": "2018-02-15T20:48:10.023+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "pacira",
        "pharmaceutical",
        "inc",
        "pacira",
        "pharmaceutical",
        "stock",
        "trading",
        "halted",
        "fda",
        "advisory",
        "committee",
        "review",
        "snda",
        "nerve",
        "block",
        "regional",
        "analgesia",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}